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Abstract
Background: Complex etiology and pathogenesis of pathophysiological components of the cardio-metabolic syndrome
have been demonstrated in humans and animal models.
Methodology/Principal Findings: We have generated extensive physiological, genetic and genome-wide gene expression
profiles in a congenic strain of the spontaneously diabetic Goto-Kakizaki (GK) rat containing a large region (110 cM, 170 Mb)
of rat chromosome 1 (RNO1), which covers diabetes and obesity quantitative trait loci (QTL), introgressed onto the genetic
background of the normoglycaemic Brown Norway (BN) strain. This novel disease model, which by the length of the
congenic region closely mirrors the situation of a chromosome substitution strain, exhibits a wide range of abnormalities
directly relevant to components of the cardio-metabolic syndrome and diabetes complications, including hyperglycaemia,
hyperinsulinaemia, enhanced insulin secretion both in vivo and in vitro, insulin resistance, hypertriglyceridemia and altered
pancreatic and renal histological structures. Gene transcription data in kidney, liver, skeletal muscle and white adipose tissue
indicate that a disproportionately high number (43–83%) of genes differentially expressed between congenic and BN rats
map to the GK genomic interval targeted in the congenic strain, which represents less than 5% of the total length of the rat
genome. Genotype analysis of single nucleotide polymorphisms (SNPs) in strains genetically related to the GK highlights
clusters of conserved and strain-specific variants in RNO1 that can assist the identification of naturally occurring variants
isolated in diabetic and hypertensive strains when different phenotype selection procedures were applied.
Conclusions: Our results emphasize the importance of rat congenic models for defining the impact of genetic variants in
well-characterised QTL regions on in vivo pathophysiological features and cis-/trans- regulation of gene expression. The
congenic strain reported here provides a novel and sustainable model for investigating the pathogenesis and genetic basis
of risks factors for the cardio-metabolic syndrome.
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Introduction
The combination of a decreased sensitivity to insulin of target
tissues (insulin resistance) and compensatory hyperinsulinaemia
predispose to the development of a collection of abnormalities
including glucose intolerance, obesity, dyslipidemia (increased
plasma triglycerides and decreased HDL cholesterol) and
hypertension [1,2]. These changes represent pathophysiological
characteristics of the cardio-metabolic syndrome and important
risk factors for coronary heart disease [3,4]. Studies in animal
models that spontaneously exhibit features of the human syndrome
contribute to the identification of causative genes for components
of the cardio-metabolic syndrome.
The wealth of phenotypic information that can be collected in
inbred strains of the laboratory rat makes it a powerful tool for
genetic studies of quantitative traits underlying complex pheno-
types [5]. Related quantitative trait loci (QTL) identified in crosses
derived from different disease rat strains often cluster [6,7],
suggesting that a proportion of genetic variants isolated in strains
selectively bred for different pathologies (type 2 diabetes,
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physiological mechanisms. Rat chromosome 1 (RNO1) which
harbors QTLs for phenotypes relevant to the cardio-metabolic
syndrome and renal failure [6,8,9,10,11,12,13,14] is a prime
example of this situation. The fact that both the spontaneously
hypertensive rat (SHR) and the diabetic Goto Kakizaki (GK) rat
carry a naturally occurring functional polymorphism in a gene
encoding an inositol 5-phosphatase (SHIP2), illustrates the
existence of common genetic and pathophysiological backgrounds
in these strains which originate from a similar Wistar outbred stock
[5]. Similarly, both GK and Otsuka Long Evans Tokushima Fatty
(OLETF) strains carry a mutation in a G-protein receptor
(GPR10) primarily associated with obesity [15].
Inbred congenic strains are powerful systems for profiling in vivo
effects of genes underlying a QTL on a broad range of phenotypes
[16]. Chromosome substitution strains (CSS) designed to carry the
entire length of a chromosome transferred from a disease strain
onto the genetic background of a control strain have been
proposed as novel tools facilitating phenotypic profiling of large
genomic regions [16,17]. We have developed a QTL substitution
congenic strain containing GK alleles across a 110 cM region of
RNO1 covering known diabetes and obesity QTLs Nidd/gk1,
transferred onto a Brown-Norway (BN) genetic background
[8,12]. By the length of the targeted chromosomal region this
congenic strain closely resembles the situation of a CSS.
Phenotype and genetic studies in an experimental cross derived
from this congenic strain have demonstrated that GK alleles in this
region account for the differences in glucose tolerance between the
congenics and the BN control [18].
Here, we carried out extensive phenotypic, genetic and genome-
wide gene expression analyses in this congenic strain to
demonstrate the combined impact of GK gene variants present
at the locus Nidd/gk1 on a wide range of phenotypes involved in
the cardio-metabolic syndrome and diabetes complications and on
cis- and trans- mechanisms of gene expression regulation in key
organs (kidney, liver, skeletal muscle and white adipose tissue) for
these diseases. This novel disease model exhibits fasting hypergly-
caemia and hyperinsulinaemia, enhanced insulin secretion, tissue
specific insulin resistance hypertriglyceridemia and structural
changes in the endocrine pancreas and the kidney. Analysis of
single nucleotide polymorphisms (SNPs) in rat strains revealed
large chromosomal regions conserved between GK, SHR and
Wistar-Kyoto (WKY) normoglycaemic controls, which can assist
in the identification of naturally occurring variants selected in both
diabetic and hypertensive strains and causing changes in
phenotypes involved in the cardio-metabolic syndrome.
Materials and Methods
Animals
We used a colony of GK/Ox rats bred locally and derived in
1995 from the GK/Par colony. BN rats were obtained from a
commercial supplier (Charles River Laboratories, Margate, UK).
The QTL substitution congenic strain BN.GK-D1Wox18/
D1Got254 (also referred as BN.GK-Nidd/gk1 throughout the
text) derived from these strains using a genetic marker assisted
breeding strategy (‘‘speed congenics’’) as previously described [19]
was maintained by brother-sister mating. This congenic was
specifically designed to contain GK alleles over a 170 Mb
(110 cM) genomic interval of chromosome 1 between markers
D1Wox18 (94.63 Mb) and D1Got254 (264.37 Mb), covering the
QTL Nidd/gk1, as well as other QTLs, introgressed onto the
genetic background of the BN strain. Early in the breeding
programme, GK alleles on the X chromosome were lost by two
consecutive breedings of male backcross animals to BN females.
All animals used in this study were systematically genotyped as
previously described [20] with microsatellite markers chosen to
accurately monitor retention of GK alleles in the congenic interval
and absence of GK allele contaminants from the genetic
background.
All experiments were carried out with male congenic rats and
controls. Animal procedures were approved by the ethical review
panel of the University of Oxford and UK Home Office licences.
Rats were allowed free access to tap water and standard laboratory
chow pellets (B&K Universal Ltd, Grimston, Aldbrough, Hull) and
were maintained on a 12-h light-dark cycle. All rats were identified
using a microchip (identity chip, Animal Care Ltd, York, UK).
Several aspects of the project (husbandry, phenotype scheduling
and data storage) was administrated using a database specifically
designed for congenic-based projects [21].
Body weight, tissue weight and basal metabolism
Body weight of the animals was determined at 2, 4, 12 and
24 weeks. At 12 and 24 weeks blood samples were collected on
EDTA via the tail vein of conscious rats fasted for 4 hours (post-
absorptive state) to measure plasma glucose and insulin, and rats
fasted overnight for 16–18 hours (fasting state) to determine
plasma concentrations of glucose, insulin and lipids. Plasma was
obtained immediately and stored at 280uC. Retroperitoneal fat
pads (RFP) were dissected in rats killed by anesthetic overdose and
weighed. Adiposity index was calculated as the ratio between RFP
weight and body weight.
Plasma concentrations of glucose, insulin, total cholesterol,
HDL-cholesterol, LDL-cholesterol, triglycerides, and phospholip-
ids were determined using commercial diagnostic kits (ABX,
Shefford, UK) on a Cobas Mira Plus automatic analyser (ABX,
Shefford, UK). Plasma NEFA were quantified on the Cobas Mira
Plus using a kit from Wako (Alpha Laboratories, Eastleigh, UK).
Immunoreactive insulin (IRI) was measured with an ELISA kit
(Mercodia, Uppsala, Sweden).
In vivo arginine induced insulin secretion test
Intraperitoneal arginine tests were performed in fasted animals
at 24 weeks of age as previously described [12]. Rats were
anesthetised using ketamine hydrochloride (95 mg/kg body
weight). A solution of L-arginine hydrochloride (0.8 g/kg body
weight) was injected. Blood samples were collected on heparin
before the injection and 5, 10, 15, 20 and 30 minutes afterwards.
Samples were spun and plasma separated for determination of
plasma IRI.
Static incubation of pancreatic islets
Insulin secretion was measured in static incubation following
overnight culture in RPMI1640 containing 5 mM glucose. Groups
of 10 size-matched islets were washed twice in 300 ml of RPMI
1640 without glucose and pre-incubated at 37uC for 1 hr in a
solution of 120 mM NaCl, 4.73 mM KCl, 2.5 mM CaCl2,
1.19 mM KH2PO4, 1.18 mM MgSO4, 10 mM Hepes (pH 7.4
with NaOH), 25 mM NaHCO3 supplemented with BSA 0.5 mg/
ml and 1 mM glucose. Sample tubes were centrifuged for 2 min at
90 g and the supernatant replaced with 300 ml of EC1
supplemented with glucose and tolbutamide as indicated. Islets
were then incubated for 1 hr at 37uC. The test tubes containing
the islets were then centrifuged for 1 min at 90 g and the
supernatant withdrawn for analysis. Pelleted islets were kept in
100 ml acid-alcohol (ratio of ethanol:H2O:HCl was 52:17:1) at
220uC until hormone measurement.
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(euglycaemic-hyperinsulinaemic clamp)
Rats in a post-absorptive state were anesthetised with an
intraperitoneal injection of pentobarbitone (30 mg/kg body
weight). One carotid artery was freed from the vagus nerve and
a catheter placed and connected to a 4 channel Biopac system with
two blood pressure transducers (SS13L, Santa Barbara, CA).
Arterial blood pressure was recorded for about 15 minutes once
the blood pressure had stabilized.
A tracheotomy was then performed prior to the euglycaemic-
hyperinsulinaemic clamp. Clamps were performed with an infusion
rate of 20 ml of insulin (0.6 U/kg/h) (Humulin S, Lilly, UK) per
minute. Exogenous glucose was simultaneously infused through the
saphenous vein in order to maintain euglycaemia. Glycaemia was
monitored for about 40 minutes until a plateau was reached for
bothglycaemiaand exogenousglucoseinfusionrate.Asolutionof2-
Deoxy[1-
3H]glucose (2DOG, Amersham, UK) (30 mCi) prepared
in 400 ml of 0.9% NaCl was then injected via the saphenous vein.
Blood samples were collected via the arterial catheter 3, 5, 10, 20,
40, 60 minutes after the injection of 2DOG. Glycaemia was
immediately determined using a pocket analyzer (Bayer, UK).
Blood samples werecollected in parallel, deproteinised in Ba(OH)2/
ZnSO4 and centrifuged. Pellets were left to evaporate and
solubilised in water for 2DOG quantification as described below.
At the end of the experiment (60 minutes post 2DOG injection),
rats were killed by pentobarbitone overdose. Skeletal muscles
(extensor digitorum [ED]-slow twitch muscle and soleus -fast
twitch muscle), liver, pancreas, RFP, brown adipose tissue (BAT),
atrium and ventricle were harvested, weighed and immediately
immersed in NaOH (1M) at 60uC for 1 hour until tissues were
dissolved. A solution of 0.5 ml HCl (1M) was then added to each
tissue digest and a 200 ml aliquot was mixed with a solution of 6%
HClO4 (perchloric acid, PCA) and Ba(OH)2/ZnSO4. After
centrifugation the supernatant was counted with the deproteinised
blood samples. The concentration of 2DOG was determined with
the equation:
PCA cpm ðÞ   ZNSO4 cpm ðÞ ðÞ |dilution factor
Tissue weight g ðÞ
0
ð
60 G
  cpm ðÞ
G ½  mg=ml
Pancreas and renal histology
At 6 months rats were fasted overnight and killed. The tail of
the pancreas and the right kidney were taken. The tail of the
pancreas was cut in half and the half closest to the spleen was fixed
in a solution of Bouin and then transferred to 70% EtOH. Samples
were embedded in paraffin and sliced (7 mm) on a Leica RM 2155
microtome. To improve accuracy of pancreas histology, sections
were taken at 10 different areas along the pancreas (150 to 200 mm
between areas). A technique of indirect labelling was used for
immunohistochemistry. Slides were rehydrated and incubated
with an anti-porcine insulin antibody (ICN). Slides were then
incubated with a peroxidase-conjugated rabbit anti-guinea pig IgG
(Dako, Ely, UK) and stained using a peroxidase substrate kit
(DAB, Vector Laboratories, Peterborough, UK). Islets were
imaged using an Olympus BX-51 microscope. The Metamorph
software was used to capture the images and the ImageJ software
available from NIH (http://rsb.info.nih.gov/ij/) was used to
determine the area of the pancreas and the islets.
Kidneys were fixed in a solution of picric acid containing
fixative (Dubosq-Brazil). After dehydration, kidneys were embed-
ded in paraffin and sectioned at 5 mm. Following staining with
hematoxylin and eosin (H&E) or periodic acid Schiff (PAS)
reagents, sections were examined qualitatively to assess glomerular
and tubular damages, thickening of glomerular basement
membranes, changes in capillary network, and presence of
intratubular casts.
SNP-based genotype analysis of the congenic interval in
BN and Wistar related strains
Genotype data of over 20,000 rat SNPs determined in BN and
BN.GK-Nidd/gk1 congenic rats, and in various colonies of WKY
and SHR rats were obtained from the STAR project (http://
www.snp-star.eu/). Full details of rat SNPs mapped to the
congenic interval are publicly available through http://www.
well.ox.ac.uk/rat_mapping_resources/SNPbased_maps.html and
summarized in Table S1.
RNA preparation
RNA samples were individually prepared from total kidney,
liver, skeletal muscle (soleus) and RFP from six BN and six
congenic rats. Total RNA was extracted twice using Trizol
reagents (Invitrogen Life Technologies, Paisley, UK) and purified
with RNeasy columns (Qiagen Ltd., Crawley, UK). RNA quality
was determined with an Agilent 2100 Bioanalyzer (Agilent
Technologies, Waldbronn, Germany).
Hybridization to Affymetrix gene expression arrays
cDNA synthesis was performed with individual RNA samples
(no pooling) using Superscript Double-Stranded cDNA Synthesis
kits (Invitrogen Ltd., Paisley, UK). Biotin-labeled cRNA was
synthesised using GeneChipH IVT Labelling Kit and purified
using the GeneChipH Sample Cleanup Module (Affymetrix ltd.,
High Wycombe, UK). Each biotinylated cRNA (15 mg) was
fragmented and individually hybridized to GeneChip Rat
expression Arrays 230 2.0 containing over 31,000 probe sets
representing approximately 28,700 different genes (Affymetrix ltd.,
High Wycombe, UK). Washing and staining procedures were
performed with streptavidin-phycoerythrin (SAPE) on a fluidics
station 450 according to the manufacturer’s protocols (Affymetrix
ltd, High Wycombe, UK). Arrays were scanned at 570 nm using
an array scanner (Agilent Technologies, Waldbronn, Germany).
Microarray experiments were compliant with MIAME (Minimum
Information About a Microarray Experiment) and both protocol
details and raw data have been deposited in ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/) under the accession number E-
MEXP-1695.
Statistical analyses
Statistical analysis of phenotypic data was performed using
SPSS v.11.0. To ensure the homogeneity of collected data across
several litters and generations of congenic and control rats, a GLM
testing for various factors (such as seasonal variation, litter size,
date of birth, date of experiment) was performed for each
phenotype. When the effect of such factors was negligible, an
independent Student’s t-test was used to compare means of
phenotypic data between the congenic and control strains.
Statistical analysis of gene transcription profiling data was
carried out with at least five array experiments per group. Analyses
were performed with the Affymetrix CEL files using the
Bioconductor packages in the R language and environment as
previously described [22]. Affymetrix data were normalized using
QTL Dissection in GK Congenics
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(LIMMA) package was used to assess statistical significance
between groups.
Results
Body weight and adiposity index
Body weight at 2 weeks was higher in congenics than in BN
(Fig. 1A) (P=4.9610
27). At weaning (4 weeks) body weight was
not statistically different between the two groups, but at 12 and
24 weeks, congenic rats were significantly heavier than BN
controls (P=3.2610
27 and 3.8610
26, respectively). Congenic
rats were heavier than GK until weaning. At 12 and 24 weeks,
GK rats were significantly heavier than congenics. RFP weight
was significantly higher in congenics than in BN rats (Fig. 1B). As a
consequence adiposity index was increased in congenics when
compared to BN (Fig. 1C), but this effect was statistically
significant (P=3.3610
24) in females only (data not shown). Both
RFP weight and adiposity index were significantly lower in
congenics than in GK rats. Overall these data indicate that GK
genetic variants in the congenics account for a proportion of the
phenotypic differences between GK and BN rats.
Plasma lipid profile and glucose homeostasis
When compared to BN controls, circulating levels of several
lipid variables were transiently altered in congenic animals at
12 weeks (Phospholipids, P=3.0610
23; NEFA, P=4.0610
24)o r
24 weeks (HDL cholesterol, P=3.0610
23) (Fig. 2). Plasma
concentrations of total, LDL and VLDL cholesterol were similar
in congenic and BN control rats, but significantly lower than in
GK rats. At both 12 and 24 weeks, concentration of circulating
triacylglycerols was significantly higher in congenics than in BN
controls, to reach levels exhibited by GK rats. These results
suggest that GK variants captured in BN.GK-Nidd/gk1 congenic
rats have a strong impact on triacylglyceride metabolism in the
GK strain whereas loci elsewhere in the genome control the
concentration of plasma cholesterol.
At 12 and 24 weeks of age, congenic rats in the post-absorptive
state (4 hours- fasting) exhibited significant elevation of glycaemia
(P=4.0610
24) and insulinaemia (P,0.05) when compared to age-
matched BN controls (Table 1). Fasted congenic rats showed mild
but statistically significant hyperglycaemia when compared to BN
at 12 weeks only (P=1.1610
24), and a 27–40% reduction of
insulinaemia at both 12 and 24 weeks, but these differences were
not statistically significant (P=0.06). These results suggest insulin
resistance in post-absorptive congenic rats and differential
adaptation to fasting in congenic and BN rats, which may affect
triacylglycerol metabolism. Marked hyperglycaemia and hyperin-
sulinaemia in the GK strain when compared to BN.GK-Nidd/gk1
congenic rats indicates that genes outside the GK interval targeted
in this congenic strain influence glucose regulation.
Owing to the magnitude of phenotype differences between GK
and congenics, which are likely caused by the combined effects of
numerous GK variants outside the congenic region in BN.GK-
Nidd/gk1 rats, further analyses of insulin sensitivity and in vivo and
in vitro insulin secretion, already well-characterized in GK , were
limited to BN and congenic rats.
Figure 1. Follow-up measure of body weight in BN, GK and
BN.GK-Nidd/gk1 congenic rats (A), and retroperitoneal fat pad
(RFP) weight (B) and adiposity index (C) in 24 weeks old rats.
Data are expressed as means6SEM. Number of rats tested is in
parentheses. *P,0.01 significantly different between congenic and BN
rats.
{P,0.01 significantly different between congenic and GK rats.
doi:10.1371/journal.pone.0002962.g001
Figure 2. Plasma lipid profile in 12- (A) and 24-weeks old (B)
BN, GK and BN.GK-Nidd/gk1 congenic rats. Data are expressed as
means6SEM. Number of rats used is reported at the bottom of the
charts. *P,0.01 significantly different between congenic and BN rats.
{P,0.01 significantly different between congenic and GK rats.
doi:10.1371/journal.pone.0002962.g002
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To investigate possible causes of hyperinsulinaemia in BN.GK-
Nidd/gk1 congenics, insulin response to an injection of arginine in
vivo was tested. Congenic rats showed significantly greater insulin
secretion 5 and 10 minutes after the arginine injection than BN
rats (P,0.005) (Fig. 3). As a consequence, the cumulative insulin
response during the test was also significantly enhanced by over
25% in congenics when compared to BN (P=0.008), thus
reflecting an overall greater capacity of congenic rats to secrete
insulin than BN.
In vitro glucose-induced insulin secretion
To test whether functional defects in pancreatic islets account
for these and previously reported [12,18] in vivo stimulatory effect
of GK alleles in chromosome 1 on insulin secretion in the
congenics, we studied glucose induced insulin secretion in isolated
islets. Islets from BN controls responded by a 12-fold increase in
insulin secretion when stimulated by high (20 mM) glucose
(Fig. 4A), whereas islets from congenic rats showed insulin
secretion increased by 15-fold upon stimulation, an effect that
was significantly higher than in BN islets. Insulin content was not
statistically different in BN and congenic strains (P=0.2) (Fig. 4B).
Insulin sensitivity
Euglycaemic-hyperinsulinaemic clamps coupled with 2DOG
quantification in organs were used to assess in vivo tissue specific
glucose transport and utilization stimulated by insulin in congenics
and controls. At 12 and 24 weeks, 2DOG content in non-oxidative
and oxidative skeletal muscles (DE and soleus, respectively), liver,
atrium and ventricle was similar in BN and congenic rats (Fig. 5).
The concentration of 2DOG in BAT was lower in congenics than
in BN rats but differences were not statistically significant
(P=0.08). We noted a significant reduction of pancreatic levels
of 2DOG in 12 week old congenic rats when compared to BN. At
Table 1. Glycaemia, insulinaemia and blood pressure variables in male BN, GK and BN.GK-Nidd/gk1 congenic rats.
Age Strains
(weeks) BN BN.GK-Nidd/gk1 GK
Glycaemia (mg/dl) Post-absorptive 12 128.364.0 (30) 136.362.4 (31) * 193.6767.33 (6) {
24 124.562.8 (26) 138.263.6 (19) * 227.7166.52 (8) {
Fasting 12 100.2660.01 (26) 116.1460.03 (14) * 175.7361.30 (12) {
24 96.1060.01 (17) 91.1760.05 (16) 148.4162.42 (4) {
Insulinaemia (mg/ml) Post-absorptive 12 0.7560.13 (29) 1.5460.16 (31) * 2.1760.11 (6) {
24 1.1260.12 (24) 2.2160.22 (20) * 3.2660.06 (8) {
Fasting 12 0.2660.01 (17) 0.1860.05 (16) 0.5160.09 (8) {
24 0.2660.01 (16) 0.1260.07 (5) 0.6460.17 (4) {
Mean BP (mmHg) 12 139613 (6) 139611 (5) 17865 (6) {
Diastolic BP (mmHg) 12 125613 (6) 123610 (5) 21866 (6) {
Systolic BP (mmHg) 12 163616 (6) 156613 (5) 20166 (6) {
Heart rate (BPM) 12 311675 (6) 405660 (5) 318626 (6)
Post-absorptive values were obtained after a 4 hour-fast and fasting values after a 12 hour-fast. Data are expressed as means6SEM. Number of animals tested is in
parentheses.
*P,0.05 significantly different between congenic and BN rats.
{P,0.05 significantly different between congenic and GK rats.
doi:10.1371/journal.pone.0002962.t001
Figure 3. Insulin response to arginine stimulation in 24 weeks old male rats of the BN and BN.GK-Nidd/gk1 congenic strains.
Immunoreactive insulin (IRI) data from BN (n=15) and congenic (n=6) rats are expressed as means6SEM. *P,0.01 significantly different between
congenic and BN rats.
doi:10.1371/journal.pone.0002962.g003
QTL Dissection in GK Congenics
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consistently significantly lower in congenic than in BN, indicating
reduced glucose transport and/or utilization in congenics. These
results show that congenic rats develop evidence of persistent
reduced biological effects of insulin (insulin resistance), which are
limited to white adipose tissue.
Blood pressure
To further document cardiovascular phenotypes linked to rat
chromosome 1 QTLs and refine insulin resistant variables in
BN.GK-Nidd/gk1 congenics, arterial blood pressure was analysed
in 24 weeks-old congenics and controls. Measures of systolic,
diastolic and mean blood pressure were similar in the rat groups
(Table 1). Heart rate was increased by 30% in congenic when
compared to BN but differences were not statistically significant
(P=0.19). These results demonstrate that GK alleles at the locus
Nidd/gk1 do not significantly alter blood pressure regulation. In
contrast, increased blood pressure in GK when compared to BN
and congenics indicates that hypertensive genetic variants may
exist elsewhere in the GK genome.
Pancreas and renal histology
Pancreas and renal morphological features were analyzed to
refine phenotype characterization of BN.GK-Nidd/gk1 congenic
rats in relation to diabetes and cardiovascular traits mapped to rat
chromosome 1 QTLs. The number of islets was similar in
congenics and BN (Fig. 6). However, the average size of the islets
was increased by over 65% in congenic when compared to BN rats
(P=6.4610
27), which may contribute to hyperinsulinaemia and
enhanced insulin secretion in congenics. Rats of the congenic
strain exhibited glomeruli with varying degrees of deposition of
eosinophilic hyaline material on the basement membranes and
within the mesangium (Fig. 7C, arrow), together with glomeruli of
normal morphology (Figs. 7C, 7D) when compared to kidney
Figure 4. Insulin response to glucose in isolated islets from BN.GK-Nidd/gk1 congenic and BN controls. Insulin secretion in response to
2 or 20 mM glucose from batch incubation of islets from BN (n=7) and congenics (n=9) (A) and insulin content derived from the same experiment
(B) are shown. *P,0.01 significantly different between congenics and BN rats.
doi:10.1371/journal.pone.0002962.g004
Figure 5. Insulin stimulated glucose uptake and utilization in 12 and 24 weeks old male rats of the BN and BN.GK-Nidd/gk1
congenic strains. Content of 2-Deoxy [1-3H]glucose per mg of tissue and per minute was measured for several organs. Data are expressed as
means6SEM. Data are from 18 rats at 12 weeks (5 BN and 13 congenics) and 16 rats at 24 weeks (10 BN and 6 congenics). DE, Digitalum extensorum;
RFP, Retroperitoneal fat pad; BAT, Brown adipose tissue. *P,0.01, **P,0.001 significantly different between congenic and BN rats.
doi:10.1371/journal.pone.0002962.g005
QTL Dissection in GK Congenics
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morphology (Figs. 7A, 7B). In addition, tubulointerstitial histo-
pathologic changes were noted in renal cortex of congenics. They
mainly consisted of focal areas of protein/carbohydrate complex
cast formations in the distal tubules and early tubular nephrosis
(data not shown). Sections of GK kidneys showed evidence of
deposition of eosinophilic hyaline material on glomerular and
tubular basement membranes and within the mesangium (Fig. 7E)
and presence of PAS positive cast within a distal tubule (Fig. 7F,
arrow).
SNP-based genotype analysis of BN.GK-Nidd/gk1
congenic, BN and Wistar related strains
Recently produced genotype data of rat SNP markers in rat
strains were used to assess the extent of genetic divergence
between the BN.GK-Nidd/gk1 congenic strain and other inbred
strains genetically or physiologically relevant to the study.
Genome-wide determination of rat SNPs in BN and congenic
rats accurately defined the region of chromosome 1 of GK origin
introgressed onto the genetic background of the BN strain in
congenic rats and verified the absence of GK contaminants
throughout the genetic background of the congenic strain. Over
12,000 SNPs were typed, including 1427 SNPs mapped to the
congenic interval, which spans 178 Mb (from EN-
SRNOSNP2783757 located at position 89.99 Mb to EN-
SRNOSNP2785224 at 267.83 Mb, corresponding to the telomer-
ic end of RNO1).
Genotype data of rat SNPs localized in the congenic interval of
the BN.GK-Nidd/gk1 strain provided an accurate determination
of genetic similarities and divergences between the BN and
Figure 6. Endocrine pancreas morphological features in BN
and BN.GK-Nidd/gk1 congenic strains. Four sections of pancreas
spaced by at least 150 mm were used to determine islets’ number (A)
and average size (B). The numbers of islets were normalized to the size
of the pancreas section. Data are expressed as means6SEM. *P,0.001,
significantly different between congenic and BN rats.
doi:10.1371/journal.pone.0002962.g006
Figure 7. Representative photomicrographs of H&E (A, C) and PAS (B, D, E, F) stained kidney sections of BN (A, B), BN.GK-Nidd/gk1
congenic (C, D) and GK rats (E, F). Focal glomerular lesions, including thickening of the glomerular basement membrane, mesangial extracellular
matrix expansion and deposition of fibrous material within the Bowman’s capsule were observed in kidneys of congenic rats (C, arrow). Original
magnification: 6400.
doi:10.1371/journal.pone.0002962.g007
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PLoS ONE | www.plosone.org 7 August 2008 | Volume 3 | Issue 8 | e2962Figure 8. SNP-based genetic similarities and differences between BN, GK, WKY, SHR and SHRSP in the region of chromosome 1 of
GK origin targeted in BN.GK-Nidd/gk1 congenic rats. Genotype data from several colonies of WKY, SHR and SHRSP are reported. For each
marker, alleles shared between the BN and one or several of these strains are shown in yellow and alleles different to the BN are shown in blue.
Heterozygous loci are shown in pink. Examples of intervals showing SNP genotype conservation or difference between stains are reported on the
right hand side. The position of genes containing functional variants in the GK rat is reported in red. Full details of SNP markers and genomic
positions are given in Table S1. SNP marker details are available through http://www.well.ox.ac.uk/rat_mapping_resources/SNPbased_maps.html.
doi:10.1371/journal.pone.0002962.g008
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strain and colonies of Wistar-related strains, i.e. WKY, SHR and
SHRSP (Table S1). There were many blocks of genotype
conservation between BN.GK-Nidd/gk1 congenics, GK and
colonies of WKY, SHR and SHRSP rats, including a large region
between 148.2 Mb and 157.6 Mb (interval 3) (Fig. 8). Conversely,
BN.GK-Nidd/gk1 congenic and GK strains exhibited specific
alleles in several genomic regions (e.g. intervals 1 and 8). In a
number of chromosomal segments (e.g. interval 6), all Wistar-
related strains but the congenic, GK and BN strains shared the
same alleles, whereas in other short genomic regions (intervals 2
and 5) congenic, GK and WKY strains carried the same alleles,
which were different to BN and the hypertensive strains. In other
instances (intervals 4 and 7), the hypertensive strains have different
alleles compared to the other strains including BN (Fig. 8). Of note
a block of genetic heterogeneity was detected in GK/Ox and GK/
Slc colonies in the genomic interval 223.8 Mb–227.4 Mb.
Gene transcription regulation in the congenic strain
To test a possible correlation between genotype conservation in
congenic and control strains and gene expression regulation,
microarray based analysis of gene transcription was carried out
with biopsies of tissues (kidney, liver, skeletal muscle and white
adipose tissue) directly relevant to insulin resistance and renal
structural changes observed in BN.GK-Nidd/gk1 congenic rats.
Evidence of significant differential transcription (P,0.05) between
congenics and BN controls was observed for 516 probesets
corresponding to 478 distinct genes (Table S2). Gene expression
patterns were fully replicated by different probesets for 38 genes
and partly discrepant results were observed for 7 genes. Gene
differential expression between congenics and BN was predomi-
nantly tissue-specific, with 411 genes (79.7%) showing evidence of
differential regulation in one tissue only (Fig. 9). Remarkably, a
very high proportion of genes differentially expressed in kidney
(60%), liver (43%), skeletal muscle (83%) and white adipose tissue
(72%) actually map to the GK chromosomal introgressed in the
BN.GK-Nidd/gk1 congenics, even though this strain and the BN
control are genetically divergent over only 5% of their genome, as
illustrated in Fig. 10. This observation strongly suggests the
existence of predominantly cis-acting influences on gene expres-
sion regulation in congenic strains.
Discussion
We have characterized the wide range of pathophysiological
features of the cardio-metabolic syndrome and genome-wide gene
expression patterns that are altered in rats of the BN.GK-Nidd/
gk1 congenic strain designed to carry alleles of the spontaneously
diabetic (type 2) GK rat across diabetes and obesity QTLs mapped
to RNO1. Hyperglycaemia, hyperinsulinaemia, hypertriglyceride-
mia, enhanced stimulated insulin secretion, insulin resistance and
increased adiposity, develop as a consequence of gene variants in
the targeted chromosomal interval that can be mapped using SNP
genotype data analysis identified in rat strains genetically related to
the GK. Phenotypic features in congenic rats are significant when
compared to BN controls, but of modest effect size when
compared to GK rats, supporting the complex and polygenic
nature of diabetes phenotypes in the GK strain.
Previously documented glucose intolerance and enhanced
glucose-stimulated insulin secretion in vivo in BN.GK-Nidd/gk1
congenics [18] have validated the most significant phenotypic
features of the QTLs originally detected in the (GKxBN) F2 cross
[12] and further confirmed in an F2 cross derived from BN.GK-
Nidd/gk1 congenic rats [18]. We have now demonstrated that rats
of this strain show a much broader spectrum of hormonal and
Figure 9. Tissue-specific patterns of genes differentially expressed between BN.GK-Nidd/gk1 congenics and BN controls. Total
number of genes showing significant differential expression (P,0.05) between congenics and BN controls in kidney, skeletal muscle (soleus), liver and
adipose tissue (retroperitoneal fat pads -RFP) are reported. The number of differentially expressed genes mapped to the GK genomic region in the
congenic strain is reported in parentheses. Details of differentially expressed genes are given in Table S2.
doi:10.1371/journal.pone.0002962.g009
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congenics both in vitro and in vivo in response to glucose or
arginine suggests that GK alleles in this region of RNO1
collectively affect b-cell function and consequently insulin release
[23,24]. This finding corroborates that at least in part there is an
alteration in b-cell depolarization or exocytosis, thus supporting
changes in the secretory machinery.
Increased islet size rather than number in BN.GK-Nidd/gk1
congenics when compared to BN rats is an additional important
feature that may contribute to enhanced insulin release. These
results are however inconsistent with impaired insulin secretion
described in a GK.F344 congenic strain targeting a short RNO1
region of the GK QTL Niddm1 [25,26], suggesting either the
predominant enhancing role of GK alleles of the BN.GK-Nidd/
gk1 congenics outside the GK.F344 congenic region on insulin
secretion, or differential effects of BN and F344 alleles on the
expression of RNO1 GK variants on insulin secretion. SNP
genotype data in RNO1 suggest that genetic differences between
GK colonies do not account for these phenotypic discrepancies, as
heterogeneity between GK/Ox and GK/Slc are located in a
genomic interval (223.8 Mb–227.4 Mb) proximal to the GK
region introgressed in GK.F344 congenic strains [26] (252 Mb–
268 Mb).
The overall net effect of GK variants in the BN.GK-Nidd/gk1
congenics on insulin secretion contributes to hyperinsulinaemia
and possibly insulin resistance. Results from euglycaemic-hyper-
insulinaemic clamps indicate reduced sensitivity to the biological
effects of insulin predominantly in white adipose tissue of BN.GK-
Nidd/gk1 congenics and a transient decrease in glucose uptake
from pancreatic tissue. Impaired insulin stimulated glucose uptake
and utilization in adipocytes of congenic rats contributes to
hypertriglyceridemia and hyperglycaemia, which in turn stimu-
lates insulin secretion. The effect of reduced pancreatic glucose
uptake on islet function of congenics remains to be further
documented. In old congenic rats, hypertriglyceridemia was
persistent and associated with significantly reduced plasma HDL
cholesterol level, which indicates that the phenotype deteriorates
with age towards the emergence of risk factors for coronary heart
disease [2]. Further analyses of features of the cardio-metabolic
syndrome showed that adiposity, body weight and heart rate were
increased in BN.GK-Nidd/gk1 congenics. Focal glomerulosclero-
sis and basal membrane thickening, which are important features
of diabetes complications in humans, provide structural evidence
of renal dysfunction in congenics.
BN.GK-Nidd/gk1 congenics, as CSS, are powerful tools for
profiling the phenotypic effects of a large number of gene variants,
which collectively are involved either directly or indirectly in multiple
pathophysiological endpoints. Among these, known GK functional
variants in the genes encoding the insulin degrading enzyme (IDE)
[27], a G-protein receptor GPR10 [15] and an inositol -phosphatase
Figure 10. Genomic position of genes differentially expressed between BN.GK-Nidd/gk1 congenics and BN controls. Expression ratio
(ER) of genes significantly differentially expressed (P,0.05) between congenics and BN in kidney, liver, skeletal muscle (soleus) and adipose tissue
(retroperitoneal fat pads -RFP) is shown. The red bar along chromosome 1 indicates the length of the GK genomic region (89.99–267.83 Mb) in
BN.GK-Nidd/gk1 congenics. Details of differentially expressed genes are given in Table S2.
doi:10.1371/journal.pone.0002962.g010
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significant impact on adiposity, hyperinsulinaemia and insulin
resistance in the congenics. However, the discrimination between
primary causes and secondary effects of one or several genetic
variants is difficult. For example glomerulosclerosis in congenic rats
may either develop as a consequence of permanent hyperglycaemia
and hyperinsulinaemia or originate from the effect of specific GK
variants.
The emergence of genotype data from large collections of rat
SNPs in multiple inbred strains (http://www.well.ox.ac.uk/
rat_mapping_resources/SNPbased_maps.html) provides impor-
tant tools for defining haplotype blocks and predicting the
localization of genes underlying altered phenotypes in BN.GK-
Nidd/gk1 congenics. With respect to the etiology of diabetes in the
GK rat, comparing SNP genotypes between Wistar related strains
(WKY, SHR, SHRSP) and BN.GK-Nidd/gk1 rats in the congenic
interval could identify naturally occurring variants originally
selected in the GK strain for their causative role in glucose
intolerance. Providing that diabetes in the GK stems from the
selective isolation of diabetes susceptibility alleles present in an
outbred colony of Wistar rats, genes involved in altered
phenotypes in the BN.GK-Nidd/gk1 congenics may map to
RNO1 regions that are genetically different between GK rats and
either hypertensive SHR/SHRSP or WKY controls. It is also
possible that these genetically related disease strains share
common etiological variants isolated following generations of
breedings of Wistar rats exhibiting glucose intolerance (GK) or
high blood pressure (SHR). The presence of a functional mutation
in SHIP2 in both SHR and GK rats [28], and its localisation in a
short congenic interval associated with hypertension in a
SHR.WKY strain combination [28], supports this hypothesis. In
addition a functional mutation in Cd36 in the SHR relates to
insulin sensitivity in adipocytes rather than directly to blood
pressure [29]. Increased density of SNPs in the congenic region of
the BN.GK-Nidd/gk1 strain is needed to test these hypotheses.
Gene expression changes in kidney and insulin sensitive organs
of BN.GK-Nidd/gk1 rats are molecular adaptations that underlie
causes and consequences of phenotypic features exhibited by this
strain. Remarkably about 50% of genes showing statistically
significant differential expression between congenics and BN map
to the GK genomic interval of the congenics, even though this
region of genetic divergence between strains only represents about
5% of the total rat genome length. These effects may indicate gene
expression regulation in cis, whereas differentially expressed genes
that map outside the congenic interval undoubtedly reflect effects
in trans and are secondary adaptations to defects caused directly of
indirectly by genes in the congenic region of GK origin. Providing
that current rat SNP data reliably reflect haplotype structure,
integration of data from SNP genotypes and transcriptomes in
BN.GK-Nidd/gk1 and BN supports cis-regulation of transcription
when differentially expressed genes map to congenic regions of
haplotype divergence between BN and GK (eg. Mesdc2, Nox4 in
RNO1 region 129–144 Mb). Conversely, a number of genes
differentially expressed fall in regions of apparent haplotype
conservation between BN and GK (eg. LOC292861, Dbp, Sult2b1
in RNO1 region 94–100 Mb), suggesting trans-regulation of
transcription. Increasing SNP density should resolve fragmenta-
tion of the haplotype structure in congenic regions of BN.GK-
Nidd/gk1 and ascertain segments of genetic divergence and
conservation between strains, thus providing information for
selecting functional and positional candidate genes.
In conclusion, we have established the pathophysiological and
genome-wide gene expression signatures of QTLs linked to diabetes
and obesity in a congenic strain, and developed SNP and haplotype
maps that can assist disease gene discovery. This congenic strain
provides a novel and sustainable model for investigating the genetic
basis of risks factors for the cardio-metabolic syndrome and
characterizing further associated phenotypes.
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